Different enzyme kinetics of midazolam in recombinant CYP3A4 microsomes from human and insect sources

Drug Metab Pharmacokinet. 2009;24(3):261-8. doi: 10.2133/dmpk.24.261.

Abstract

In vitro drug metabolism techniques with human CYP c-DNA expressed systems are frequently used to predict human drug metabolism in vivo. The aim of this study was to compare midazolam enzyme kinetics in recombinant expressed CYP3A4 microsomes from human and insect cells. The amounts of 1'- hydroxymidazolam and 4-hydroxymidazolam formed in CYP3A4 microsomes from transfected human liver epithelial cells (T5-3A4 microsomes) and baculovirus-infected insect cells (with and without coexpressed cytochrome b(5)) were analysed by LC-MS. Enzyme kinetic parameters were estimated by nonlinear regression. Mean K(m) for the formation of 1'-hydroxymidazolam was 3- and 4-fold higher in T5-3A4 microsomes than in insect microsomes (p<0.05), with and without coexpressed cytochrome b(5), respectively. Only minor differences in V(max) were observed and the higher K(m) in T5-3A4 microsomes was reflected by significantly lower Cl(int) compared to insect microsomes (p<0.001). For formation of 1'-hydroxymidazolam, human microsomes displayed Michaelis-Menten kinetics, while insect microsomes showed substrate inhibition kinetics. The different enzyme kinetics of midazolam observed in recombinant CYP3A4 microsomes from human and insect sources, especially the substantially higher K(m) obtained in human microsomes compared to insect microsomes, should be further evaluated since it may have implications for correlations to in vivo situation.

MeSH terms

  • Animals
  • Baculoviridae / genetics
  • Cytochrome P-450 CYP3A / metabolism*
  • Humans
  • Insecta
  • Kinetics
  • Microsomes / enzymology*
  • Microsomes, Liver / enzymology*
  • Midazolam / metabolism*
  • Recombinant Proteins / metabolism

Substances

  • Recombinant Proteins
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Midazolam